Senores Pharmaceuticals Limited (BOM:544319)
689.45
-6.30 (-0.91%)
At close: Aug 29, 2025
Senores Pharmaceuticals Company Description
Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.
The company offers critical care pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supplements, and urinary tract generics; and management and consultancy services.
Senores Pharmaceuticals Limited was incorporated in 2017 and is based in Ahmedabad, India.
Senores Pharmaceuticals Limited
Country | India |
Founded | 2017 |
Industry | Pharmaceutical Preparations |
Employees | 194 |
CEO | Swapnil Shah |
Contact Details
Address: South Tower Ahmedabad, Gujarat 380054 India | |
Phone | 91 79 2999 9857 |
Website | senorespharma.com |
Stock Details
Ticker Symbol | 544319 |
Exchange | Bombay Stock Exchange |
Fiscal Year | April - March |
Reporting Currency | INR |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Swapnil Shah | Chief Executive Officer |
Deval Shah | Chief Financial Officer |
Chetan Shah | Chief Operating Officer |